Controversies in Establishing Biosimilarity: Extrapolation of Indications and Global Labeling Practices.
- Published in:
- BioDrugs, 2016, v. 30, n. 1, p. 1, doi. 10.1007/s40259-015-0154-1
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2016 AND VI 30 AND IP 1
Results: 6
1
2
Switching Between Epoetins: A Practice in Support of Biosimilar Use.
- Published in:
- BioDrugs, 2016, v. 30, n. 1, p. 27, doi. 10.1007/s40259-015-0155-0
- By:
- Publication type:
- Article
3
A Retrospective Study on the Efficacy of Trastuzumab in HER2-Positive and Tamoxifen-Refractory Breast Cancer with Brain Metastasis.
- Published in:
- BioDrugs, 2016, v. 30, n. 1, p. 33, doi. 10.1007/s40259-015-0156-z
- By:
- Publication type:
- Article
4
Immunomodulating Drugs Based on Poxviral Proteins.
- Published in:
- BioDrugs, 2016, v. 30, n. 1, p. 9, doi. 10.1007/s40259-016-0158-5
- By:
- Publication type:
- Article
5
Asfotase Alfa in Perinatal/Infantile-Onset and Juvenile-Onset Hypophosphatasia: A Guide to Its Use in the USA.
- Published in:
- BioDrugs, 2016, v. 30, n. 1, p. 41, doi. 10.1007/s40259-016-0161-x
- By:
- Publication type:
- Article
6
Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3111, a Trastuzumab Biosimilar, and Trastuzumab in Healthy Japanese Adult Males: Results of a Randomized Trial.
- Published in:
- BioDrugs, 2016, v. 30, n. 1, p. 17, doi. 10.1007/s40259-015-0153-2
- By:
- Publication type:
- Article